Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children

Pneumococcal conjugate vaccine (PCV) has the potential to interact with other vaccines containing diphtheria toxin-like antigens (such as those found in the DTP vaccine) upon sequential administration. This is attributed to the similarity of the diphtheria toxoid antigen to the carrier protein used...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashani, Mohamed, Rashid, Harunor, Mulholland, Kim, Booy, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471833/
https://www.ncbi.nlm.nih.gov/pubmed/28702295
http://dx.doi.org/10.1186/s41479-016-0016-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471833/
https://www.ncbi.nlm.nih.gov/pubmed/28702295
http://dx.doi.org/10.1186/s41479-016-0016-8

Ejemplares similares